The evolution of carbon monoxide into medicine.

The evolution of carbon monoxide into medicine.
复制标题

一氧化碳演变为医学。

DOI:
--
复制
发表时间:
2009
期刊:
影响因子:
2.5
通讯作者:
L. Otterbein
L. Otterbein
中科院分区:
医学4区
文献类型:
--
作者:
L. Otterbein

文献摘要

参考文献

被引文献

相似文献

一氧化碳(CO)——一种广为人知的有毒气体分子——具有强大的功效和疗效,这一发现不仅改变了我们对一氧化碳的看法,而且在巨大的矛盾中,导致了利用一氧化碳治疗各种疾病的临床试验。有充分的临床前证据表明,低浓度的二氧化碳对啮齿动物、大型动物和人类的多种疾病有益。 CO 尤其对炎症性疾病具有潜在益处。随着二氧化碳在临床上的进展,我们不断加深对其功能的理解,特别是随着潜在临床应用数量的扩大。一氧化碳在细胞水平上的作用机制取决于疾病和实验重点,但唯一不变的是一氧化碳可以重建体内平衡。
The discovery that carbon monoxide (CO)-a highly publicized toxic gas molecule-can have powerful benefits and curative effects not only changed how we view CO, but has, with tremendous contradiction, resulted in clinical trials of CO for the treatment of various pathologies. There is sound preclinical evidence that, at a low concentration, CO has benefits in numerous and diverse diseases in rodents, large animals, and humans. CO especially has potential benefits in inflammatory disorders. As CO moves ahead in the clinic, we continue to advance our understanding of how it functions, especially as the number of potential clinical applications expands. CO's mechanisms of action at the cellular level depend on the disease and the experimental focus, but the one constant is that CO reestablishes homeostasis.
DOI: 10.1016/s0002-9440(10)63515-8
发表时间: 2003-10-01
影响因子: 6
作者:
Nakao, A;Kimizuka, K;Murase, N
通讯作者: Murase, N
DOI: 10.1073/pnas.94.20.10919
发表时间: 1997-09-30
影响因子: 11.1
作者:
Poss, KD;Tonegawa, S
通讯作者: Tonegawa, S
DOI: 10.1182/blood.v99.12.4443
发表时间: 2002-06-15
期刊: BLOOD
影响因子: 20.3
作者:
Peyton, KJ;Reyna, SV;Durante, W
通讯作者: Durante, W
DOI: 10.1016/j.jtcvs.2008.06.026
发表时间: 2008-10
影响因子: 6
作者:
Kohmoto, Junichi;Nakao, Atsunori;Sugimoto, Ryujiro;Wang, Yinna;Zhan, JiangHua;Ueda, Hideo;McCurry, Kenneth R.
通讯作者: McCurry, Kenneth R.
DOI: 10.1073/pnas.94.20.10925
发表时间: 1997-09-30
影响因子: 11.1
作者:
Poss, KD;Tonegawa, S
通讯作者: Tonegawa, S